A Neuroprotective Function for the Hematopoietic Protein Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
Open Access
- 25 April 2007
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 28 (1), 29-43
- https://doi.org/10.1038/sj.jcbfm.9600496
Abstract
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic cytokine responsible for the proliferation, differentiation, and maturation of cells of the myeloid lineage, which was cloned more than 20 years ago. Here we uncovered a novel function of GM-CSF in the central nervous system (CNS). We identified the GM-CSF α-receptor as an upregulated gene in a screen for ischemia-induced genes in the cortex. This receptor is broadly expressed on neurons throughout the brain together with its ligand and induced by ischemic insults. In primary cortical neurons and human neuroblastoma cells, GM-CSF counteracts programmed cell death and induces BCL-2 and BCL-Xl expression in a dose- and time-dependent manner. Of the signaling pathways studied, GM-CSF most prominently induced the PI3K-Akt pathway, and inhibition of Akt strongly decreased antiapoptotic activity. Intravenously given GM-CSF passes the blood—brain barrier, and decreases infarct damage in two different experimental stroke models (middle cerebral artery occlusion (MCAO), and combined common carotid/distal MCA occlusion) concomitant with induction of BCL-Xl expression. Thus, GM-CSF acts as a neuroprotective protein in the CNS. This finding is remarkably reminiscent of the recently discovered functionality of two other hematopoietic factors, erythropoietin and granulocyte colony-stimulating factor in the CNS. The identification of a third hematopoietic factor acting as a neurotrophic factor in the CNS suggests a common principle in the functional evolution of these factors. Clinically, GM-CSF now broadens the repertoire of hematopoietic factors available as novel drug candidates for stroke and neurodegenerative diseases.Keywords
This publication has 38 references indexed in Scilit:
- New targets for established proteins: exploring G-CSF for the treatment of strokeTrends in Pharmacological Sciences, 2007
- Long-term gene expression changes in the cortex following cortical ischemia revealed by transcriptional profilingExperimental Neurology, 2006
- Developing Granulocyte-Colony Stimulating Factor for the Treatment of Stroke: Current Status of Clinical TrialsStroke, 2006
- Toward a Multimodal Neuroprotective Treatment of StrokeStroke, 2006
- Granulocyte‐colony stimulating factor is neuroprotective in a model of Parkinson's diseaseJournal of Neurochemistry, 2006
- GM-CSF action in the CNS decreases food intake and body weightJCI Insight, 2005
- Role of granulocyte—macrophage colony—stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injuryJournal of Neurosurgery: Spine, 2005
- Restriction-mediated Differential Display (RMDD) Identifies pip92 as a Pro-Apoptotic Gene Product Induced during Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2004
- Neuroprotective Effect of Granulocyte Colony–Stimulating Factor After Focal Cerebral IschemiaStroke, 2003
- Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant ProteinsScience, 1985